MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059950 A) filed by Noida Institute Of Engineering Technology Pharmacy Institute on May 12, 2026, for An In Situ Gelling Nasal Drug Formulation.
Inventors include Madhurima; and Swati Yadav.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: An in situ gelling nasal drug formulation is disclosed for intranasal delivery of a therapeutic agent. The formulation includes a drug containing phase, aqueous vehicle, trigger responsive gelling polymer, mucoadhesive polymer, buffering and tonicity system, and optional stabilizing excipients. The composition remains liquid before administration and forms a gelled mucosal depot after exposure to nasal physiological conditions. The depot improves mucosal residence and supports controlled drug release while maintaining compatibility with nasal applicators and patient acceptable administration.
Disclaimer: Curated by HT Syndication.
